Biological consequences of human immunodeficiency virus type 1 envelope polymorphism: Does variation matter?

Journal of General Virology

Volumn 77, Issue 12, 1996, Pages 2905-2919

  McKeating, Jane A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ANTIGENIC VARIATION; ANTIGENICITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS CELL INTERACTION; VIRUS CLASSIFICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030468316     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-12-2905     Document Type: Review

References (145)

1. Alkhatib, G. C., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M. & Berger, E. A. (1996). CC-CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage tropic HIV-1. Science 272, 1955-1958.
2. Allan, J. S., Whitehead, E. M., Strout, K., Short, M., Kanda, P., Hart, T. K. & Bugelski, P. J. (1991). Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation. AIDS Research and Human Retroviruses 8, 2011-2020.
3. Andeweg, A. C., Leeflang, P., Osterhaus, A. D. & Bosch, M. L. (1993). Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. Journal of Virology 67, 3232-3239.
4. Ashkenazi, A., Smith, D. H., Marsters, S. A., Riddle, L., Gregory, T. J., Ho, D. D. & Capon, D. J. (1991). Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. [Erratum 89, 1517.] Proceedings of the National Academy of Sciences, USA 88, 7056-7060.
5. Asjo, B., Morfeldt-Manson, L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K. & Fenyo, E. M. (1986). Replicative properties of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet ii, 660-662.
6. Back, N. K. J. T., Smit, L., de Jong, J., Keulen, W., Schutten, M., Goudsmit, J. & Tersmette, M. (1994). An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization. Virology 199, 431-438.
7. Blacklow, S. C., Lu, M. & Kim, P. S. (1995). A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34, 14955-14962.
8. Bosch, M. L., Andeweg, A. C., Schipper, R. & Kenter, M. (1994). Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type I surface glycoprotein through AAT triplet reiteration. Journal of Virology 68, 7566-7569.
9. Bou-Habib, D. C., Roderiquez, G., Oravecz, T., Berman, P. W., Lusso, P. & Norcross, M. A. (1994). Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. Journal of Virology 68, 6006-6013.
10. Boyd, M. T., Simpson, G. R., Cann, A. J., Johnson, M. A. & Weiss, R. A. (1993). A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism. Journal of Virology 67, 3649-3652.
11. Broder, C. C., Earl, P. L., Long, D., Abedon, S. T., Moss, B. & Doms, R. W. (1994). Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Proceedings of the National Academy of Sciences, USA 91, 11699-11703.
12. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W., Sawyer, L. S., Hendry, R. M., Dunlop, N., Nara, P. L. & Others (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
13. Cann, A. J., Churcher, M. J., Boyd, M., O'Brien, W., Zhao, J. Q., Zack, J. & Chen, I. S. (1992). The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism. Journal of Virology 66, 305-309.
14. Cao, Y., Ho, D. D., Todd, J., Kokka, R., Urdea, M., Lifson, J. D., Piatak, M., Jr, Chen, S, Hahn, B. H. & Saag, S. M. (1995 a). Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma. AIDS Research and Human Retroviruses 11, 353-361.
15. Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D. D. (1995 b). Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection [see comments]. New England Journal of Medicine 332, 201-208.
16. Cheng-Mayer, C., Seto, D., Tateno, M. & Levy, J. A. (1988). Biologic features of HIV-1 that correlate with virulence in the host. Science 240, 80-82.
17. Chesebro, B., Wehrty, K., Nishio, J. & Perryman, S. (1992). Macrophage tropic HIV isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell tropic isolates: definition of critical amino acids involved in cell tropism. Journal of Virology 66, 6547-6554.
18. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L, MacKay, C. R., Larosa, G., Newman, W., Gerard, N., Gerard, C. & Sodroski, J. (1996). The B chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
19. Clements, G. J., Price-Jones, M. J., Stephens, P. E., Sutton, C., Shulz, T. F., Clapham, P. R., McKeating, J. A., McClure, M. O., Thomson, S., Marsh, M., Kay, J., Weiss, R. A. & Moore, J. P. (1991). The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion? AIDS Research and Human Retroviruses 7, 3-15.
20. Cocchi, F., Devico, A., Garzino-Demo, A., Arya, S., Gallo, R. & Lusso, P. (1995). Identification of RANTES, MIP-1α and MIP-1β as the major HIV-suppressive factors produced by CD8+ T-cells. Science 270, 1811-1815.
21. Conley, A. J., Kessler, J. A. N., Boots, L. J., Tung, J. S., Arnold, B. A., Keller, P.M., Shaw, A. R. & Emini, E. A. (1994). Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody. Proceedings of the National Academy of Sciences, USA 91, 3348-3352.
22. Connor, R. I. & Ho, D. D. (1994). Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. Journal of Virology 68, 4400-4408.
23. Connor, R., Mohri, H., Cao, Y. & Ho, D. D. (1993). Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. Journal of Virology 67, 1772-1777.
24. Cornelissen, M., Mulder Kampinga, G., Veenstra, J., Zorgdrager, F., Kuiken, C., Hartman, S., Dekker, J., Van Der Hoek, L., Sol, C. & Coutinho, R. (1995). Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. Journal of Virology 69, 1810-1818.
25. Daar, E. S. & Ho, D. D. (1991). Relative resistance of primary HIV-1 isolates to neutralization by soluble CD4. American Journal of Medicine 90, 22s-26s.
26. Dalgleish, A. G., Beverly, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F. & Weiss, R. A. (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
27. de Jong, J. J., De Ronde, A., Keulen, W., Tersmette, M. & Goudsmit, J. (1992). Minimal requirements for the HIV-1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology 66, 6777-6780.
28. Delwart, E. L., Sheppard, H. W., Walker, B. D., Goudsmit, J. & Mullins, J. I. (1994). Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. Journal of Virology 68, 6672-6683.
29. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. & Landau, N. R. (1996). Identification of a major coreceptor for primary isolates of HIV-1. Nature 381, 661-666.
30. Donaldson, Y. K., Bell, J. E., Holmes, E. C., Hughes, E. S., Brown, H. K. & Simmonds, P. (1994). In vivo distribution and cytopathology of variants of HIV-1 showing restricted sequence variability in the V3 loop. Journal of Virology 68, 5991-6005.
31. Doranz, B. J., Rucker, R., Yi, Y., Smyth, R. J., Samson, S., Peiper, S. C., Parmentier, M., Collman, R. C. & Doms, R. W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the B-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
32. Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P. J., Koup, R. A., Moore, J. P. & Paxton, W. A. (1996). HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
33. Earl, P. L. & Moss, B. (1993). Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein. AIDS Research and Human Retroviruses 9, 589-594.
34. Earl, P. L., Doms, R. W. & Moss, B. (1990). Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein. Proceedings of the National Academy of Sciences, USA 87, 648-652.
35. Earl, P. L., Broder, C. C., Long, D., Lee, S. A., Peterson, J., Chakrabarti, S., Doms, R. W. & Moss, B. (1994). Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. Journal of Virology 68, 3015-3026.
36. Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner Racz, K. & Haase, A. T. (1993). Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362, 359-362.
37. Fast, P. E., Johnston, M. I., Killen, J. Y. & The AIDS Vaccine Evaluation Group (1995). HIV vaccine clinical trials: experience of the NIAID AIDS vaccine evaluation group. Dixieme Colloque des Cent Gardes, 283-290.
38. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV entry factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
39. Fenouillet, E. & Jones, I. M. (1995). The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. Journal of General Virology 76, 1509-1514.
40. Fenyo, E. M., Morfeldt-Manson, L., Chiodi, F., Lind, A., Von Gegerfelt, A., Albert, J., Olausson, E. & Asjo, B. (1988). Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. Journal of Virology 62, 4414-4419.
41. Fenyo, E. M., Albert, J. & McKeating, J. A. (1996). The role of the humoral immune response in HIV infection. AIDS 10, S97-S106.
42. Fouchier, R. A., Freed, E. O. & Martin, M. A. (1994). Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. Journal of Virology 68, 2503-2512.
43. Fox, D. G., Balfe, P., Palmer, C. P., May, J. C., Arnold, C. & McKeating, J. A. (1997). Length polymorphism within the second variable region of the HIV-1 envelope glycoprotein affects accessibility of the receptor binding site. Journal of Virology (in press).
44. Freed, E. O. & Martin, M. A. (1994). Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. Journal of Virology 68, 2503-2512.
45. Gabriel, J. L. & Mitchell, W. M. (1993). Proposed atomic structure of a truncated human immunodeficiency virus glycoprotein gp120 derived by molecular modeling: target CD4 recognition and docking mechanism. Journal of Virology 90, 4186-4190.
46. Gorny, M., Moore, J. P., Conley, A. J., Karwowska, S., Sodroski, J., Williams, C., Burda, S., Boots, L. J. & Zolla-Pazner, S. (1994). Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1. Journal of Virology 68, 8312-8320.
47. Gartner, S., Markovits, P., Markovitz, D., Kaplan, M., Gallo, R. & Popovic, M. (1986). The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233, 215-219.
48. Groenink, M., Fouchier, R. A., Broersen, S., Baker, C. H., Koot, M., Van't Wout, A. B., Huisman, H. G., Miedema, F., Tersmette, M. & Schuitemaker, H. (1993). Relation of phenotype evolution of HIV-1 to envelope V2 configuration. Science 260, 1513-1516.
49. Groenink, M., Moore, J. P., Broersen, S. & Schuitemaker, H. (1995). Equal levels of gp120 retention and neutralization resistance of phenotypically distinct primary human immunodeficiency virus type 1 variants upon soluble CD4 treatment. Journal of Virology 69, 523-527.
50. Helseth, E., Olshevsky, U., Furman, C. & Sodroski, J. (1991). Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. Journal of Virology 65, 2119-2123.
51. Ho, D. D., Neumann, A. U. & Perelson, A. S. (1995). Rapid turnover of plasmid virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
52. Hurtley, S. M. & Heleneius, A. (1989). Protein oligomerization in the endoplasmic reticulum. Annual Review of Cell Biology 5, 277-307.
53. Hwang, S. S., Boyle, T. J., Lyerly, H. K. & Cullen, B. R. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
54. Jeffs, S. A., McKeating, J. A., Lewis, S., Craft, H., Biram, D., Stephens, P. E. & Brady, R. L. (1996). Antigenicity of truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein. Journal of General Virology 77, 1403-1410.
55. Kabat, D., Kozak, S. L., Wehrty, K. & Chesebro, B. (1994). Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. Journal of Virology 68, 2570-2577.
56. Karlsson, A., Parsmyr, K., Sandstrom, E., Fenyo, E. M. & Albert, J. (1994). MT-2 cell tropism as a prognostic marker for disease progression in HIV-1 infection. Journal of Clinical Microbiology 32, 364-370.
57. Katinger, H. (1994). Human monoclonal antibodies for passive immunotherapy of HIV-1. Antibiotics and Chemotherapy 46, 25-37.
58. Keller, R., Peden, K., Paulous, S., Montagnier, L. & Cordonnier, A. (1993). Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion. Journal of Virology 67, 6253-6258.
59. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. C. & Montagnier, L. (1984). T lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
60. Koenig, S., Gendelam, H., Orenstein, J., Dalcanto, M., Pezeshkpour, G., Yungbluth, M., Janotta, F., Aksamit, A., Martin, M. & Fauci, A. (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089-1092.
61. Koito, A., Harrowe, G., Levy, J. A. & Cheng-Mayer, C. (1994). Functional role of the V1V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. Journal of Virology 68, 2253-2259.
62. Koito, A., Stamatatos, L. & Cheng-Mayer, C. (1995). Small amino acid sequence changes within the V2 domain can affect the function of T-cell line tropic HIV-1 envelope gp120. Virology 206, 878-884.
63. Koot, M., Vos, A. H. V., Keet, R. P. M., De Goede, R. E., Dercksen, M. W., Terpstra, F. G., Coutinho, R. A., Miedema, F. & Tersmette, M. (1992). HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 co-cultivation assay. AIDS 6, 49-54.
64. Korber, B. T., Kunstman, K. J., Patterson, B. K., Furtado, M., McEvilly, M. M., Levy, R. & Wolinsky, S. M. (1994 a). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. Journal of Virology 68, 7467-7481.
65. Korber, B. T., MacInnes, K., Smith, R. F. & Myers, G. (1994 b). Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. Journal of Virology 68, 6730-6744.
66. Kostrikis, L. G., Cao, Y., Ngai, H., Moore, J. P. & Ho, D. D. (1996). Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. Journal of Virology 70, 445-458.
67. Lamers, S. L., Sleasman, J. W., She, J. X., Barrie, K. A., Pomeroy, S. M., Barrett, D. J. & Goodenow, M. M. (1993). Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. Journal of Virology 67, 3951-3960.
68. LaRosa, G. J., Davide, J. P., Weinhold, K., Waterbury, J. A., Profy, A. T., Lewis, J. A., Langlois, A. J., Dreesman, G. R., Boswell, R. N., Shadduck, P. & Others (1990). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications [letter]. Science 251, 811.
69. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N. & Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. Journal of Biological Chemistry 265, 10373-10382.
70. Li, Y., Luo, L., Rasool, N. & Kang, C. Y. (1993). Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. Journal of Virology 67, 584-588.
71. Louwagie, J., Janssens, W., Mascola, J., Heyndrickx, L., Hegerich, P., Van Der Groen, G., McCutchan, F. E. & Burke, D. S. (1993). Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. Journal of Virology 69, 263-271.
72. Lukashov, V. V., Kuiken, K. & Goudsmit, J. (1995). Intrahost human immunodeficiency virus type 1 evolution is related to the length of the immunocompetent period. Journal of Virology 69, 6911-6916.
73. McKeating, J. A., McKnight, A. & Moore, J. P. (1991). Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. Journal of Virology 65, 852-860
74. McKeating, J. A., Thali, M., Furman, C., Karwowska, S., Gorny, M. K., Cordell, J., Zolla-Pazner, S., Sodroski, J. & Weiss, R. A. (1992). Amino acid residues of the human immunodeficiency virus type I gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190, 134-142.
75. McKeating, J. A., Shotton, C., Cordell, J., Graham, S., Balfe, P., Sullivan, N., Charles, M., Blomstedt, A., Olofsson, S., Kayman, S. C., Wu, Z., Pinter, A., Dean, C., Sodroski, J. & Weiss, R. A. (1993). Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of HIV-1 gp120. Journal of Virology 67, 4932-4944.
76. McKeating, J. A., Shotton, C., Jeffs, S., Brady, L., Fenyo, E. M., Bjorndal, A. & Balfe, P. (1996 a). Truncated HIV-1 gp120 envelope glycoprotein elicits a cross-clade neutralizing immune response. Journal of Virology (submitted).
77. McKeating, J. A., Zhang, Y. J., Arnold, C., Frederiksson, R., Fenyo, E. M. & Balfe, P. (1996 b). Chimeric viruses expressing primary envelope glycoproteins of HIV-1 show increased sensitivity to neutralization by human sera. Virology 220, 450-460.
78. McKeating, J. A., Shotton, C., Jeffs, S., Palmer, C., Hammond, A., Lewis, J., Oliver, K., May, J. & Balfe, P. (1996 c). Immunogenicity of full length and truncated forms of the human immunodeficiency virus type 1 envelope glycoprotein. Immunology Letters 51, 101-105.
79. McKnight, A., Weiss, R. A., Shotton, C., Takeuchi, Y., Hoshino, H. & Clapham, P. R. (1995). Change in tropism upon immune escape by human immunodeficiency virus. Journal of Virology 69, 3167-3170.
80. Mackewicz, C. E., Blackbourn, D. J. & Levy, J. A. (1995). CD8 + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92, 2308-2312.
81. Malykh, A., Reitz, M. S., Jr, Louie, A., Hall, L. & Lori, F. (1995). Multiple determinants for growth of human immunodeficiency virus type 1 in monocyte-macrophages. Virology 206, 646-650.
82. Mansky, L. & Temin, H. (1995). Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. Journal of Virology 69, 5087-5094.
83. Mascola, J. R., Louwagie, J., McCutchan, F. E., Fischer, C. L., Hegerich, P. A., Wagner, K. F., Fowler, A. K., McNeil, J. G. & Burke, D. S. (1994). Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. Journal of Infectious Diseases 169, 48-54.
84. Mascola, J. R., Snyder, S. W., Weislow, O. S., Belay, S. M., Belshe, R. B., Schwartz, D. H., Clements, M. L., Dolin, R., Graham, B. S., Gorse, G. J., Keefer, M. C., McElrath, M. J., Walker, M. C., Wagner, K. F., McNeil, J. G., McCutchan, F. E. & Burke, D. S. (1996). Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. Journal of Infectious Diseases 173, 340-348.
85. Modrow, S., Hahn, B. H., Shaw, G. M., Gallo, R. C., Wong-Staal, F. & Wolf, H. (1987). Computer assisted analysis of envelope protein sequences of seven HIV-1 isolates: predictions of antigenic epitopes in conserved and variable regions. Journal of Virology 61, 570-580.
86. Moore, J. P. & Ho, D. D. (1995). HIV-1 neutralization : the consequences of viral adaption to growth on T-cells. AIDS 9, S117-S136.
87. Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142.
88. Moore, J., McKeating, J. A., Huang, Y. X., Ashkenazi, A. & Ho, D. D. (1992). Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. Journal of Virology 66, 235-243.
89. Moore, J. P., Sattentau, Q. J., Yoshiyama, H., Thali, M., Charles, M., Sullivan, N., Poon, S. W., Fung, M. S., Traincard, F., Pinkus, M. & Others (1993 a). Probing the structure of the V2 domain of human immunodeficiency virus type I surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains. Journal of Virology 67, 6136-6151.
90. Moore, J. P., Thali, M., Jameson, B. A., Vignaux, F., Lewis, G. K., Poon, S. W., Charles, M., Fung, M. S., Sun, B., Durda, P. J., Akerblom, L., Wahren, B., Ho, D. D., Sattentau, Q. J. & Sodroski, J. (1993 b). Immunochemical analysis of the gp120 surface glycoprotein of HIV-1: probing the structure of the C4 and V4 domain and interaction of the C4 domain with the V3 loop. Journal of Virology 67, 4785-4796.
91. Moore, J. P., Jameson, B. A., Weiss, R. A. & Sattentau, Q. J. (1993 c). HIV-cell fusion. In Viral Fusion Mechanism, pp. 233-289. Edited by J. Bentz. Boca Raton, Fla.: CRC Press.
92. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F. R., Burton, D. R. & Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. Journal of Virology 69, 101-109.
93. Murphy, A. L., Lewis, J., Albert, J., Balfe, P. & McKeating, J. A. (1996). Antigenic variation within the CD4 receptor binding site of primary human immunodeficiency virus type 1 gp120 proteins. Journal of Virology (submitted).
94. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology 67, 6642-6647.
95. Myers, G. (1994). HIV: between past and future. AIDS Research and Human Retroviruses 10, 1317-1324.
96. Nowak, M. A. & May, R. M. (1993). AIDS pathogenesis: mathematical models of HIV and SIV infections. AIDS 7, S3-S18.
97. Nowak, M., Anderson, R. M., McLean, A. R., Wolfs, T. F., Goudsmit, J. & May, R. M. (1991). Antigenic diversity thresholds and the development of AIDS. Science 254, 963-969.
98. Nyambi, P. N., Nkengasong, J., Peeters, M., Simon, F., Eberle, J., Janssens, W., Fransen, K., Willems, B., Vereecken, K., Heyndrickx, L. & Others (1995). Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. Journal of Infectious Diseases 172, 1228-1237.
99. Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W. & Sodroski, J. (1990). Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. Journal of Virology 64, 5701-5707.
100. Owens, R. J. & Compans, R. W. (1990). The human immunodeficiency virus type 1 envelope glycoprotein acquires aberrant intermolecular disulfide bonds that may prevent normal proteolytic processing. Virology 179, 827-833.
101. Palmer, C., Balfe, P., Fox, D., May, J. C., Frederiksson, R., Fenyo, E. M. & McKeating, J. A. (1996). Functional characterization of the V1V2 region of HIV-1. Virology 220, 436-449.
102. Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P. & Fauci, A. S. (1993). HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358.
103. Paxton, W. A., Martin, S., Tse, D., O'Brien, T., Scumick, J., Van Devanter, N., Padian, N., Braun, J., Kotler, D., Wolinski, S. & Koup, R. (1996). Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high risk sexual exposures. Nature Medicine 2, 412-417.
104. Pollard, S. R., Rosa, M. D., Rosa, J. J. & Wiley, D. C. (1992). Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO Journal 11, 585-591.
105. Pope, M., Betjes, M., Romani, N., Hirmand, H., Cameron, P., Hoffman, L., Gazelter, S., Schuler, G. & Steinman, R. (1994). Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398.
106. Rao, Z., Belyaev, A. S., Fry, E., Roy, P., Jones, I. M. & Stuart, D. I. (1995). Crystal structure of SIV matrix antigen and implications for virus. Nature 378, 743-747.
107. Richardson, T. M., Jr, Stryjewski, B. L., Broder, C. C., Hoxie, J. A., Mascola, J. R., Earl, P. L. & Doms, R. W. (1996). Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein. Journal of Virology 70, 753-762.
108. Sabino, E., Pan, L. Z., Cheng-Mayer, C. & Mayer, A. (1994). Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates : an analysis of tat and C2-V3 env regions. AIDS 8, 901-909.
109. Sattentau, Q. J. & Moore, J. P. (1991). Conformational changes induced in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. Journal of Experimental Medicine 174, 407-415.
110. Sattentau, Q. J., Dalgleish, A. G., Weiss, R. A. & Beverley, P. C. (1986). Epitopes of the CD4 antigen and HIV infection. Science 234, 1120-1123.
111. Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F. & Poignard, P. (1993). Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. Journal of Virology 67, 7383-7893.
112. Scarlatti, G., Leitner, T., Hodara, V., Halapi, E., Rossi, P., Albert, J. & Fenyo, E. M. (1993). Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. AIDS 7, S45-S48.
113. Schuitemaker, H., Koot, M., Koostra, N. A., Dercksen, M. W., de Goede, R. E., Van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F. & Tersmette, M. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection : progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. Journal of Virology 66, 1354-1360.
114. Schulz, T. F., Jameson, B. A., Lopalco, L., Siccardi, A. G., Weiss, R. A. & Moore, J. P. (1992). Conserved structural features in the interaction between retroviral surface and transmembrane glycoproteins? AIDS Research and Human Retroviruses 8, 1571-1580.
115. Shaw, G. M. (1995). Viral and cellular dynamics in HIV-1 infection. Dixieme Colloque des Cent Gardes, 9-11.
116. Shioda, T., Oka, S., Ida, S., Nokihara, K., Toriyoshi, H., Mori, S., Takebe, Y., Kimura, S., Shimada, K., Nagai, Y. & Others (1994). A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. Journal of Virology 68, 7689-7696.
117. Shotton, C., Arnold, C., Sattentau, Q., Sodroski, J. & McKeating, J. A. (1995). Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. Journal of Virology 69, 222-230.
118. Simmonds, P., Zhang, L. Q., McOmish, F., Balfe, P., Ludlam, C. A. & Brown, A. J. (1990). Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo: implications for models of HIV pathogenesis. Journal of Virology 65, 6266-6276.
119. Soto-Ramierez, L. E., Renjifo, B., McLane, M. F., Lee, T. H. & Essex, M. (1995). Differential growth of HIV-1 sub-types in Langerhans' cells: implications for vaccine development. Dixieme Colloque des Cent Gardes, 127-130.
120. Spira, A. I. & Ho, D. D. (1995). Effect of different donor cells on human immunodeficiency virus type 1 replication and selection in vitro. Journal of Virology 69, 422-429.
121. Spira, A., Marx, P. A., Patterson, B. K., Mahoney, J, Koup, R. A., Wolinsky, S. M. & Ho, D. D. (1996). Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. Journal of Experimental Medicine 183, 215-225.
122. Stamatatos, L. & Cheng Mayer, C. (1995). Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. Journal of Virology 69, 6191-6198.
123. Sullivan, N., Thali, M., Furman, C., Ho, D. D. & Sodroski, J. (1993). Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. Journal of Virology 67, 3674-3679.
124. Sullivan, N., Sun, Y., Li, J., Hofmann, W. & Sodroski, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. Journal of Virology 69, 4413-4122.
125. Tersmette, M., Gruters, R. A., De Wolf, F., De Goede, R. E., Lange, J. M., Schellekens, P. T., Goudsmit, J., Huisman, H. G. & Miedema, F. F. (1989 a). Evidence for a role of virulent human immunodeficiency virus variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. Journal of Virology 63, 2118-2125.
126. Tersmette, M., Lange, J. M., De Goede, R. E., De Wolf, F., EftinkSchattenkerk, J. K., Schellekens, P. T., Coutinho, R. A., Huisman, H. G., Goudsmit, J. & Miedema, F. F. (1989 b). Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i, 983-985.
127. Trkola, A., Pomales, A. B., Yuan, H., Korber, B., Maddon, P. J., Allaway, G. P., Katinger, H., Barbas, C. F. R., Burton, O. R. & Ho, D. D (1995). Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. Journal of Virology 69, 6609-6617.
128. Turner, S., Tizard, R., Demarinis, J., Pepinsky, R. B., Zullo, J., Schooley, R. & Fisher, R. (1992). Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Proceedings of the National Academy of Sciences, USA 89, 1335-1339.
129. Wain-Hobson, S. (1989). HIV genome variability in vivo. AIDS 3(Suppl. 1), S13-S18.
130. Wain-Hobson, S., Szathmary, E., Szamado, S. & Meyerhans, A. (1995). An antigenic demise of the immune system, or AIDS. Dixieme Colloque Des Cent Gardes, 17-24.
131. Wang, N., Zhu, T. & Ho, D. D. (1995). Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype. Journal of Virology 69, 2708-2715.
132. Wang, W. K., Essex, M. & Lee, T. H. (1996). Single amino acid substitution in constant regions one or four of gp120 causes the phenotype of a HIV-1 variant with mutations in hypervariable regions I and II to revert. Journal of Virology 70, 607-611.
133. Warrier, S., Pinter, A., Honnen, W. J., Girard, M., Muchmore, E. & Tilley, S. (1994). A novel glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent neutralizing chimpanzee monoclonal antibody. Journal of Virology 68, 4636-4642.
134. Wei, X., Ghosh, S. K., Taylor, M. E., Johnson, J. A., Emini, E. A.,
135. Wenisch, E., Jungbauer, A., Tauer, C., Reiter, M., Gruber, G., Steindl, F. & Katinger, H. (1989). Isolation of human monoclonal antibody isoproteins by preparative isoelectric focusing in immobilized pH gradients. Journal of Biochemical and Biophysical Methods 18, 309-322.
136. Westervelt, P., Henkel, T., Trowbridge, D. B., Orenstein, J., Heuser, J., Gendelman, H. E. & Ratner, L. (1992). Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. Journal of Virology 66, 3925-3931.
137. Willey, R. L. & Martin, M. A. (1993). Association of HIV-1 envelope glycoprotein with particles depends upon interactions between the third variable and conserved regions of gp120. Journal of Virology 67, 3639-3643.
138. Wolinsky, S. M., Korber, B. T. M., Neumann, A. U., Daniels, M., Kunstman, K. J., Whetsell, A. J., Furtado, M. R., Cao, Y. Z., Ho, D. D., Safrit, J. T. & Koup, R. A. (1996). Adaptive evolution of HIV-1 during natural course of infection. Science 272, 537-542.
139. Wrin, T., Loh, T. P., Vennari, J. C., Schuitemaker, H. & Nunberg, J. H. (1995). Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera. Journal of Virology 69, 39-48.
140. Wu, Z., Kayman, S. C., Honnen, W., Revesz, K., Chen, H., Vijh Warrier, S., Tilley, S. A., McKeating, J., Shotton, C. & Pinter, A. (1995). Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. Journal of Virology 69, 2271-2278.
141. Wyatt, R., Thali, M., Tilley, S., Pinter, A., Posner, M., Ho, D., Robinson, J. & Sodroski, J. (1992). Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. Journal of Virology 66, 6997-7004.
142. Wyatt, R., Sullivan, N., Thali, M., Repke, H., Ho, D., Robinson, J., Posner, M. & Sodroski, J. (1993). Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. Journal of Virology 67, 4557-4565.
143. Wyatt, R., Moore, J., Accola, M., Desjardin, E., Robinson, J. & Sodroski, J. (1995). Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding. Journal of Virology 69, 5723-5733.
144. Zhang, L. Q., MacKenzie, P., Cleland, A., Holmes, E. C., Brown, A. J. & Simmonds, P. (1993). Selection For specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. Journal of Virology 67, 3345-3356.
145. Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A. & Ho, D. D. (1993). Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261, 1179-1181.